# Safety and Tolerability of I-040302 in Children and Young Adults With Solitary Bone Cysts

> **NCT00459641** · PHASE2 · WITHDRAWN · sponsor: **Kuros Biosurgery AG**

## Conditions studied

- Bone Cysts

## Interventions

- **DRUG:** I-040302
- **OTHER:** Standard of Care

## Key facts

- **NCT ID:** NCT00459641
- **Lead sponsor:** Kuros Biosurgery AG
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2012-12
- **Primary completion:** 2014-06
- **Final completion:** 2019-07
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Stopped before any site initiation or any recruitment due to change in overall product development plan
- **Last updated:** 2012-07-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00459641

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00459641, "Safety and Tolerability of I-040302 in Children and Young Adults With Solitary Bone Cysts". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00459641. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*